Regulation of the natural killer cell receptor repertoire

Annual Review of Immunology

Volumn 19, Issue , 2001, Pages 291-330

  Raulet, D H ^a   Vance, R E ^a   McMahon, C W ^a  

^a University of California Berkeley   (United States)

Author keywords

CD94 NKG2; Inhibitory receptor; KIR; Ly49; MHC

Indexed keywords

CD8 ANTIGEN; CD94 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ALLELE; CELL POPULATION; GENE EXPRESSION; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOBLAST; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STOCHASTIC MODEL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD94; ANTIGENS, LY; CHIMERA; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, MHC CLASS I; GENOMIC IMPRINTING; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MACROMOLECULAR SUBSTANCES; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; RECEPTORS, IMMUNOLOGIC; SELF TOLERANCE; STOCHASTIC PROCESSES; T-LYMPHOCYTE SUBSETS;

EID: 0035056004     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.19.1.291     Document Type: Review

References (187)

1. Biology of natural killer cells
2. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
3. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response
4. Role of natural killer cells in innate resistance to protozoan infections
5. Severe herpes virus infections in an adolescent without natural killer cells
6. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity
7. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype
8. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity
9. Rejection of bone marrow allografts by mice with severe combined immunodeficiency (SCID)
10. Host resistance directed selectively against H-2-deficient lymphoma variants
11. Biology and genetics of hybrid resistance
12. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy
13. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice
14. Rejection of class I MHC-deficient hemopoietic cells by irradiated MHC-matched mice
15. MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity
16. - bone marrow in chimeric mice
17. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
18. Viral subversion of the immune system
19. + IL-2 activated natural killer cells
20. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex
21. Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules
22. A natural killer cell receptor specific for a major histocompatibility complex class I molecule
23. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties
24. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors
25. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers
26. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand
27. Ly-49 multigene family expressed by IL-2-activated NK cells
28. Ly-49 multigene family. New members of a superfamily of type II membrane proteins with lectin-like domains
29. Expression analysis of new Ly49 genes: Most transcripts of Ly49j lack the transmembrane domain
30. Identification of a human member of the Ly-49 multigene family
31. The human Ly-49L gene
32. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specifities
33. Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intra-cellular domains
34. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
35. Molecular cloning of NKB1: A natural killer cell receptor for HLA-B allotypyes
36. Killer cell inhibitory receptors: Diversity, specificity and function
37. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
38. Human diversity in killer cell inhibitory receptor genes
39. Gene arrangement of the killer cell inhibitory receptor family on human chromosome 19q13.4 detected by fiber-FISH
40. The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster
41. Plasticity in the organization and sequences of human KIR/ILT gene families
42. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells
43. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits
44. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
45. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor
46. b
47. HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C
48. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
49. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
50. The Ly49 family: Genes proteins and recognition of class I MHC
51. Receptors for HLA class-I molecules in human natural killer cells
52. NKB1: A natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules
53. Functions of nonclassical MHC and non-MHC-encoded class I molecules
54. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen
55. The selective down-regulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
56. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors
57. Identification of four subsets of human CD3-CD 16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition
58. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors
59. The Qa-1b molecule binds to a large subpopulation of murine NK cells
60. Allelic exclusion of Ly49 family genes encoding class I-MHC-specific receptors on NK cells
61. Diversity of NK cell receptor repertoire in adult and neonatal mice
62. A novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1
63. Recruitment of tyrosine phosphatase HCP by the NK cell inhibitory receptor
64. Human and mouse killer-cell inhibitory receptors recruit Ptp1c and Ptp1d protein tyrosine phosphatases
65. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C
66. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation
67. Differential association of phosphatases with hematopoietic co-receptors bearing immunoreceptor tyrosine-based inhibition motifs
68. Signal transduction during natural killer cell activation: Inside the mind of a killer
69. Arousal and inhibition of human NK cells
70. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
71. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
72. Novel ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages
73. The CD2-subset of the Ig superfamily of cell surface molecules: Receptor-ligand pairs expressed by NK cells and other immune cells
74. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells
75. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
76. The NK1.1 antigen in NK-mediated F1 antiparent killing in vitro
77. Establishment of monoclonal anti-NK-1.1 antibody
78. p46, a novel natural killer cell-specific surface molecule that mediates cell activation
79. Pan natural killer cell monoclonal antibodies and their relationship to the NK1.1 antigen
80. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells
81. The Ly49D receptor activates murine natural killer cells
82. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors
83. Mouse Ly-49D recognizes H-2D(d) and activates natural killer cell cytotoxicity
84. Nonstochastic coexpression of activation receptors on murine natural killer cells
85. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E
86. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors
87. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells
88. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
89. Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain
90. KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties
91. An activating immunoreceptor complex formed by NKG2D and DAP10
92. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice
93. AP12-deficient mice fail to develop autoimmunity due to impaired antigen priming
94. Toward a quantitative analysis of the repertoire of class I MHC-specific inhibitory receptors on natural killer cells
95. Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1
96. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic
97. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire
98. Allelic inactivation regulates olfactory receptor gene expression
99. Independent and epigenetic regulation of the interleukin-4 alleles in CD4+ T cells
100. Monoallelic expression of the interleukin-2 locus
101. Regulation of IL-4 expression by activation of individual alleles
102. Allele-specific expression patterns of interleukin-2 and pax-5 revealed by a sensitive single-cell RT-PCR analysis
103. Acquisition of Ly49 receptor expression by developing natural killer cells
104. Role of Qa-1(b)-binding receptors in the specificity of developing NK cells
105. + cells into T cells
106. Murine fetal natural killer cells are functionally and structurally distinct from adult natural killer cells
107. Cutting edge: Expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49-cells: A possible mechanism of tolerance during NK cell development
108. HLA class I-specific inhibitory receptors in human T lymphocytes: Interleukin 15-induced expression of CD94/NKG2A in superantigen or alloantigen-activated CD8+ T cells
109. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15
110. Stochastic acquisition of Qa1 receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets
111. - cells can distinguish between major histocompatibility complex class I(hi) and class I(lo) target cells: Evidence for a Ly-49-independent negative signaling receptor
112. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells
113. Clonal acquisition of inhibitory Ly49 receptors on differentiating NK cell precursors is successively restricted and regulated by stromal cell class I MHC
114. Clonal analysis of NK cell development from bone marrow progenitors in vitro: Orderly acquisition of receptor gene expression
115. Evidence for a similar or common mechanisms for natural killer cell activity and resistance to hemopoietic grafts
116. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets
117. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice
118. Altered natural killer cell repertoire in Tap-1 mutant mice
119. - mice
120. b heavy chains
121. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection
122. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome)
123. Class I-deficient hematopoietic cells and nonhematopoietic cells dominantly induce unresponsiveness of NK cells to class I-deficient bone marrow grafts
124. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo
125. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene
126. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice
127. Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity
128. Major histocompatibility complex genes determine natural killer cell tolerance
129. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand
130. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire
131. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I deficient mice
132. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype
133. Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development
134. Tolerance and alloreactivity of the Ly49D subset of murine NK cells
135. Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation
136. Host MHC class I molecules modulate in vivo expression of a NK cell receptor
137. The NK2.1 receptor is encoded by Ly-49C and its expression is regulated by MHC class I alleles
138. Missing self recognition by natural killer cells in MHC class I transgenic mice. A 'receptor calibration' model for how effector cells adapt to self
139. NK cell receptor calibration: Effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells
140. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in NK cell development
141. Location-specific regulation of transgenic Ly49A receptors by major histocompatibility complex class I molecules
142. External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells
143. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1
144. The role of Ly49A and 5E6 (Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts
145. Natural killer cell development and function precede alpha beta T cell differentiation in mouse fetal thymic ontogeny
146. A population of early fetal thymocytes expressing Fc gamma RII/III contains precursors of T lymphocytes and natural killer cells
147. Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes
148. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function
149. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes
150. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: Molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells
151. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations
152. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients
153. Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals
154. The Ly-49 family: Regulation of cytotoxicity and cytokine production in murine CD3+ cells
155. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors
156. Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors
157. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors
158. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity
159. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody
160. A novel functional cell surface dimer (kp43) serves as accessory molecule for the activation of a subset of human gamma delta T cells
161. Mouse CD1-specific NK1 T cells: Development, specificity, and function
162. Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains
163. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: Impairment of specific cytolytic functions
164. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
165. C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: Differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity
166. KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement
167. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes
168. Clonal populations oft cells in normal elderly humans: The T cell equivalent to "benign monoclonal gammapathy"
169. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells
170. Unexpected expansions of CD8-bearing cells in old mice
171. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: Expression of NK related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production
172. Inhibition of gamma delta T cell recognition by receptors for MHC class I molecules
173. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles
174. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes
175. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: Association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases
176. Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: A regulated mechanism that controls T-cell activation and function
177. Regulation of T cell function by NK cell receptors for classical MHC class I molecules
178. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection
179. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor
180. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors
181. Modulation of T-cell functions in KIR2DL3 (CD158b) transgenic mice
182. Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes
183. A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function
184. + T cells
185. Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins